Imolife Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Bareilly, Uttar Pradesh, India, established in 2017.
2017 Bareilly, Uttar Pradesh, India Active
Last Updated:
Access Report
About Imolife Pharmaceuticals Private Limited

Imolife Pharmaceuticals Private Limited, a active private limited company, was established on 25 January 2017 in Bareilly, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290UP2017PTC089460. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Anjani Saxena (Director), Subodh Chandra Saxena (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 08 State Bank Colony Surkha, Bareilly, Uttar Pradesh, 243005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290UP2017PTC089460

  • Registration Number

    089460

  • Incorporation Date

    25 January 2017

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 9 Year, 18 Days
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** 19.83%
  • Profit Growth **** 105.75%
  • Ebitda **** 111.28%
  • Net Worth 0.39%
  • Total Assets **** 4.68%
Company report

Imolife Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Imolife Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Imolife Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anjani Saxena Director 25 Jan 2017 Current
Subodh Chandra Saxena Director 25 Jan 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Imolife Pharmaceuticals.

Imolife Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.83% increase. The company also saw a substantial improvement in profitability, with a 105.75% increase in profit. The company's net worth moved up by a moderate rise of 0.39%.

Imolife Pharmaceuticals revenue growth over time
Imolife Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.83%
*******
*******
*******
*******
Revenue from Operations
*******
 19.83%
*******
*******
*******
*******
Total Assets
*******
 4.68%
*******
*******
*******
*******
Profit or Loss
*******
 105.75%
*******
*******
*******
*******
Net Worth
*******
 0.39%
*******
*******
*******
*******
EBITDA
*******
 111.28%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Imolife Pharmaceuticals?

Unlock access to Imolife Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Imolife Pharmaceuticals?

Unlock and access historical data on people associated with Imolife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Imolife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imolife Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Imolife Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Imolife Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Imolife Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Anjani Saxena was appointed as a Director was appointed as a Director on 25 Jan 2017 & has been associated with this company since 9 years 18 days . was completed.

  • Director Appointment

    The activity Subodh Chandra Saxena was appointed as a Director was appointed as a Director on 25 Jan 2017 & has been associated with this company since 9 years 18 days . was completed.

  • Company Incorporation

    The activity Imolife Pharmaceuticals Private Limited was registered on 25 Jan 2017 with Roc Kanpur & aged 9 years 18 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Imolife Pharmaceuticals Private Limited?

The CIN of Imolife Pharmaceuticals Private Limited is U24290UP2017PTC089460.

Where is Imolife Pharmaceuticals Private Limited headquartered?

Imolife Pharmaceuticals Private Limited is headquartered at 08 State Bank Colony Surkha, Bareilly, Uttar Pradesh, 243005.

When was Imolife Pharmaceuticals Private Limited incorporated?

Imolife Pharmaceuticals Private Limited was incorporated on 25 January 2017.

Who are the current directors of Imolife Pharmaceuticals Private Limited?

The current directors of Imolife Pharmaceuticals Private Limited are

What is the primary industry of Imolife Pharmaceuticals Private Limited?

The primary industry of Imolife Pharmaceuticals Private Limited is Chemicals.

Is Imolife Pharmaceuticals Private Limited a listed company?

Imolife Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Imolife Pharmaceuticals Private Limited?

The authorized capital of Imolife Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Imolife Pharmaceuticals Private Limited?

The compliance status of Imolife Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available